DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies.

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

The Business Research Company The Business Research Company's Encephalomyelitis Global Market Report 2025 – Market Size, Trends, And Global ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Antibody-drug conjugates (ADCs ... QTOF instruments can typically achieve 50 ppm or better mass accuracy for heavy chains (50 kDa, with ±2.5 Da). This window is sufficient for the identification of ...

Here, we demonstrate that the molecular chaperone heat shock protein A2 (HSPA2), a member of the 70 kDa heat shock protein (HSP70) family, is asymmetrically expressed in the late 2-cell stage of mouse ...